Estrogen	B:C0014939
and	O
Progesterone	O
hormone	O
receptor	O
expression	O
in	O
oral	O
cavity	I:C0151546
cancer	I:C0151546
.	O

Estrogen	O
and	O
Progesterone	B:C0033308
hormone	O
receptor	O
expression	O
in	O
oral	O
cavity	I:C0151546
cancer	I:C0151546
.	O

Estrogen	O
and	O
Progesterone	O
hormone	B:C0019932
receptor	O
expression	O
in	O
oral	O
cavity	I:C0151546
cancer	I:C0151546
.	O

Estrogen	O
and	O
Progesterone	O
hormone	O
receptor	O
expression	O
in	O
oral	B:C0151546
cavity	I:C0151546
cancer	I:C0151546
.	O

Recent	O
studies	O
have	O
shown	O
an	O
increase	O
in	O
the	O
incidence	O
of	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
(	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
)	O
in	O
younger	O
patients	O
.	O

Recent	O
studies	O
have	O
shown	O
an	O
increase	O
in	O
the	O
incidence	O
of	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
(	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
)	O
in	O
younger	O
patients	O
.	O

The	O
hypothesis	O
that	O
tumors	B:C0027651
could	O
be	O
hormonally	O
induced	O
during	O
pregnancy	O
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	O
factors	I:C0035648
alcohol	O
or	O
tobacco	O
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

The	O
hypothesis	O
that	O
tumors	O
could	O
be	O
hormonally	B:C0019932
induced	O
during	O
pregnancy	O
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	O
factors	I:C0035648
alcohol	O
or	O
tobacco	O
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

The	O
hypothesis	O
that	O
tumors	O
could	O
be	O
hormonally	O
induced	O
during	O
pregnancy	B:C0032961
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	O
factors	I:C0035648
alcohol	O
or	O
tobacco	O
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

The	O
hypothesis	O
that	O
tumors	O
could	O
be	O
hormonally	O
induced	O
during	O
pregnancy	O
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	B:C0035648
factors	I:C0035648
alcohol	O
or	O
tobacco	O
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

The	O
hypothesis	O
that	O
tumors	O
could	O
be	O
hormonally	O
induced	O
during	O
pregnancy	O
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	O
factors	I:C0035648
alcohol	B:C0085762
or	O
tobacco	O
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

The	O
hypothesis	O
that	O
tumors	O
could	O
be	O
hormonally	O
induced	O
during	O
pregnancy	O
or	O
in	O
young	O
female	O
patients	O
without	O
the	O
well	O
-	O
known	O
risk	O
factors	I:C0035648
alcohol	O
or	O
tobacco	B:C0040336
abuse	I:C0040336
seems	O
to	O
be	O
plausible	O
.	O

Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	B:C0034833
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	B:C0034833
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	B:C0936012
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	B:C0026639
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	B:C0221198
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	B:C0456483
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	B:C1302751
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	B:C1302751
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
(	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
)	O
and	O
Progesterone	O
Receptor	I:C0034833
(	O
Progesterone	O
Receptor	I:C0034833
)	O
expression	O
were	O
analyzed	O
in	O
normal	O
oral	O
mucosa	I:C0026639
(	O
n=5	O
)	O
,	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
simple	O
hyperplasia	I:C0456483
,	O
n=11	O
;	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=35	O
)	O
,	O
and	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
.	O

OSCCs	B:C0585362
were	O
stratified	O
in	O
a	O
young	O
female	O
(	O
n=7	O
)	O
study	O
cohort	O
and	O
older	O
patients	O
(	O
n=46	O
)	O
.	O

OSCCs	O
were	O
stratified	O
in	O
a	O
young	O
female	O
(	O
n=7	O
)	O
study	O
cohort	B:C0599755
and	O
older	O
patients	O
(	O
n=46	O
)	O
.	O

In	O
the	O
young	O
female	O
study	O
cohort	B:C0599755
three	O
patients	O
(	O
n=3/7	O
)	O
developed	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
during	O
or	O
shortly	O
after	O
pregnancy	O
.	O

In	O
the	O
young	O
female	O
study	O
cohort	O
three	O
patients	O
(	O
n=3/7	O
)	O
developed	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
during	O
or	O
shortly	O
after	O
pregnancy	O
.	O

In	O
the	O
young	O
female	O
study	O
cohort	O
three	O
patients	O
(	O
n=3/7	O
)	O
developed	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
during	O
or	O
shortly	O
after	O
pregnancy	B:C0032961
.	O

Breast	B:C0678222
cancer	I:C0678222
tissues	O
were	O
used	O
as	O
positive	O
control	O
for	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
expression	O
.	O

Breast	O
cancer	I:C0678222
tissues	B:C0040300
were	O
used	O
as	O
positive	O
control	O
for	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
expression	O
.	O

Breast	O
cancer	I:C0678222
tissues	O
were	O
used	O
as	O
positive	O
control	O
for	O
Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
expression	O
.	O

Breast	O
cancer	I:C0678222
tissues	O
were	O
used	O
as	O
positive	O
control	O
for	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	B:C0034833
Receptor	I:C0034833
expression	O
.	O

Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
expression	O
was	O
found	O
in	O
four	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=4/35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
(	O
n=5/46	O
,	O
11	O
%	O
)	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
expression	O
was	O
found	O
in	O
four	O
oral	B:C0221198
precursor	I:C0221198
lesions	I:C0221198
(	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=4/35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
(	O
n=5/46	O
,	O
11	O
%	O
)	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
expression	O
was	O
found	O
in	O
four	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
squamous	B:C1302751
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=4/35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
(	O
n=5/46	O
,	O
11	O
%	O
)	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
expression	O
was	O
found	O
in	O
four	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	B:C1302751
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=4/35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
(	O
n=5/46	O
,	O
11	O
%	O
)	O
.	O

Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
expression	O
was	O
found	O
in	O
four	O
oral	O
precursor	I:C0221198
lesions	I:C0221198
(	O
squamous	O
intraepithelial	I:C1302751
neoplasia	I:C1302751
,	O
SIN	O
I	I:C1302751
-	I:C1302751
III	I:C1302751
,	O
n=4/35	O
,	O
11	O
%	O
)	O
and	O
in	O
five	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
specimen	O
(	O
n=5/46	O
,	O
11	O
%	O
)	O
.	O

The	O
five	O
Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
positive	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
samples	O
were	O
older	O
male	O
patients	O
.	O

The	O
five	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
positive	B:C1446409
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
samples	O
were	O
older	O
male	O
patients	O
.	O

The	O
five	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
positive	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
samples	O
were	O
older	O
male	O
patients	O
.	O

All	O
patients	O
within	O
the	O
young	O
female	O
study	O
cohort	B:C0599755
were	O
negatively	O
stained	O
for	O
both	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
.	O

All	O
patients	O
within	O
the	O
young	O
female	O
study	O
cohort	O
were	O
negatively	B:C0205160
stained	O
for	O
both	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
.	O

All	O
patients	O
within	O
the	O
young	O
female	O
study	O
cohort	O
were	O
negatively	O
stained	O
for	O
both	O
Estrogen	B:C0665341
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	O
Receptor	I:C0034833
.	O

All	O
patients	O
within	O
the	O
young	O
female	O
study	O
cohort	O
were	O
negatively	O
stained	O
for	O
both	O
Estrogen	O
Receptor	I:C0665341
alpha	I:C0665341
and	O
Progesterone	B:C0034833
Receptor	I:C0034833
.	O

ER	B:C0034804
expression	O
could	O
be	O
regarded	O
as	O
a	O
seldom	O
risk	O
factor	I:C0035648
for	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
.	O

ER	O
expression	O
could	O
be	O
regarded	O
as	O
a	O
seldom	O
risk	B:C0035648
factor	I:C0035648
for	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
.	O

ER	O
expression	O
could	O
be	O
regarded	O
as	O
a	O
seldom	O
risk	O
factor	I:C0035648
for	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
.	O

Progesterone	B:C0034833
Receptor	I:C0034833
expression	O
seems	O
to	O
be	O
not	O
relevant	O
for	O
the	O
development	O
of	O
oral	O
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
.	O

Progesterone	O
Receptor	I:C0034833
expression	O
seems	O
to	O
be	O
not	O
relevant	O
for	O
the	O
development	O
of	O
oral	B:C0585362
squamous	I:C0585362
cell	I:C0585362
carcinoma	I:C0585362
.	O

